Tigecycline in febrile neutropenic patients with haematological malignancies: a retrospective case documentation in four university hospitals.
about
The Antibiotic Drug Tigecycline: A Focus on its Promising Anticancer PropertiesThe prevention and management of infections due to multidrug resistant organisms in haematology patientsDiagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).Empirical antimicrobial treatment in haemato-/oncological patients with neutropenic sepsis.
P2860
Tigecycline in febrile neutropenic patients with haematological malignancies: a retrospective case documentation in four university hospitals.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Tigecycline in febrile neutrop ...... in four university hospitals.
@en
type
label
Tigecycline in febrile neutrop ...... in four university hospitals.
@en
prefLabel
Tigecycline in febrile neutrop ...... in four university hospitals.
@en
P2093
P2860
P1433
P1476
Tigecycline in febrile neutrop ...... n in four university hospitals
@en
P2093
A Glasmacher
C Hahn-Ast
C Leyendecker
C M Nellessen
G Marklein
K S Schwab
M von Lilienfeld-Toal
P Brossart
P2860
P2888
P304
P356
10.1007/S15010-013-0524-X
P577
2013-08-25T00:00:00Z